Documents

This report authored by Realize and the National Coordinating Committee on HIV and Aging (NCC) and the research database provide a snapshot of the HIV and aging research underway in Canada at a single point in time.

Aging and older people living with HIV, their carers, and representatives of community-based HIV organizations can refer to the database to identify research projects that are currently taking place in their jurisdiction. This information may facilitate increased community participation in the research process, whether through research participation, research team membership, or advocacy for future research on particular topics or with specific communities.

Principal investigators and research teams can use these resources to identify gaps in the HIV and aging research landscape, information which may help them to shape future research questions. They can also use the database to identify potential collaborators who share a mutual interest in researching particular aspects of HIV and aging.

Research funders and policymakers can reference this report and database to better understand how resources are being allocated within this field of research, to inform research priority-setting activities, and to identify projects that may produce evidence needed to inform decision-making.

The Pan-Canadian Research Agenda on HIV, Aging and Older Adulthood is a tool created by the National Coordinating Committee on HIV and Aging to guide decision-making by four interested parties:

1) Research Funders and Grant Review Committees
2) Principal Investigators and Research Team Members
3) Policy Makers and Policy Change Advocates
4) Institutions, Residential Care Settings and Community-Based Organizations

The recommendations are relevant to stakeholders engaged in most types of HIV- and aging-related
research and evidence production, including epidemiological studies, community-based research
projects, biomedical and clinical trials, implementation science initiatives and program evaluation.
There are two notable exceptions. The NCC does not have the expertise to make recommendations
regarding priorities for basic science research and drug development.